ArticleScientific reports2022

HSV-1 0∆NLS vaccine elicits a robust B lymphocyte response and preserves vision without HSV-1 glycoprotein M or thymidine kinase recognition.

Grzegorz B Gmyrek et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.